In the BioHarmony Drug Report Database

"Preview" Icon

Calcipotriene

Dovonex, Sorilux (calcipotriene) is a small molecule pharmaceutical. Calcipotriene was first approved as Dovonex on 1993-12-29. It is used to treat psoriasis in the USA. The pharmaceutical is active against vitamin D3 receptor. Calcipotriene’s patents are valid until 2028-05-07 (FDA).

 

Trade Name

 

Dovonex, Sorilux
 

Common Name

 

calcipotriene
 

ChEMBL ID

 

CHEMBL1200666
 

Indication

 

psoriasis
 

Drug Class

 

Vitamin D analogues

Image (chem structure or protein)

Calcipotriene structure rendering